DANIEL GUTIERREZ: Open Payments
NPI 1982663654 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$262 in 4 payments from 4 companies in 2025. Trend: 2023 $210 · 2024 $339 · 2025 $262
Food & beverage: $262
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 1 | $121 |
| Teva Pharmaceuticals USA, Inc. | 1 | $87 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
Products named: INVEGA SUSTENNA, UZEDY, REXULTI, FANAPT.
Industry payments across TX — which companies pay providers there.
